UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Annals of oncology, 2006-06, Vol.17 (6), p.935-944

2006

Volltextzugriff (PDF)

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

Journal of translational medicine, 2015-06, Vol.13 (1), p.204-204, Article 204

2015

Volltextzugriff (PDF)

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Annals of oncology, 2007-04, Vol.18 (4), p.701-708

2007

Volltextzugriff (PDF)

VA.2 Hormone therapy in BC patients with co-morbidities

Critical reviews in oncology/hematology, 2007-11, Vol.64, p.S18-S18

Crivellari, D

2007

Volltextzugriff (PDF)

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Annals of oncology, 2012-06, Vol.23 (6), p.1436-1441

2012

Volltextzugriff (PDF)

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Annals of oncology, 2012-11, Vol.23 (11), p.2852-2858

2012

Volltextzugriff (PDF)

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Annals of oncology, 2004-06, Vol.15 (6), p.875-884

2004

Volltextzugriff (PDF)

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Annals of oncology, 2011-09, Vol.22 (9), p.1981-1987

2011

Volltextzugriff (PDF)

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Annals of oncology, 2011-10, Vol.22 (10), p.2216-2226

2011

Volltextzugriff (PDF)

First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA study

Annals of oncology, 2012-01, Vol.23 (1), p.111-118

2012

Volltextzugriff (PDF)

Identifying optimal adjuvant treatment for individual patients: young age is still an issue?

Annals of oncology, 2010-02, Vol.21 (2), p.430-431

2010

Volltextzugriff (PDF)

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients

Future oncology (London, England), 2015-05, Vol.11 (10), p.1493-1500

2015

Volltextzugriff (PDF)

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

Cancer chemotherapy and pharmacology, 2009-09, Vol.64 (4), p.673-680

2009

Volltextzugriff (PDF)

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?

British journal of cancer, 2012-03, Vol.106 (6), p.1247-1247

2012

Volltextzugriff (PDF)

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

The Lancet (British edition), 2000-05, Vol.355 (9218), p.1869-1874

2000

Volltextzugriff (PDF)

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

Annals of oncology, 2008-09, Vol.19 (9), p.1541-1546

2008

Volltextzugriff (PDF)

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Annals of oncology, 2010-02, Vol.21 (2), p.245-254

2010

Volltextzugriff (PDF)

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

Annals of oncology, 2006-02, Vol.17 (2), p.262-269

2006

Volltextzugriff (PDF)

1084 Neoadjuvant Trastuzumab and Paclitaxel Combination Induces a High Rate of Pathological Complete Responses in Locally Advanced Breast Cancer by Exploiting Host Antitumor Immunity

European journal of cancer (1990), 2012-07, Vol.48, p.S261-S261

2012

Volltextzugriff (PDF)

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Annals of oncology, 2001-03, Vol.12 (3), p.353-356

2001

Volltextzugriff (PDF)

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

Annals of oncology, 2000-03, Vol.11 (3), p.373-374

2000

Volltextzugriff (PDF)

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Annals of oncology, 2008-08, Vol.19 (8), p.1393-1401

2008

Volltextzugriff (PDF)

Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring

Annals of oncology, 2006-05, Vol.17 (5), p.807-812

2006

Volltextzugriff (PDF)

Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors

Critical reviews in oncology/hematology, 2005-02, Vol.53 (2), p.125-131

2005

Volltextzugriff (PDF)

Breast carcinoma during pregnancy : International recommendations from an expert meeting

Cancer, 2006-01, Vol.106 (2), p.237-246

2006

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(213)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Humans
(143)
Female
(128)
Life Sciences & Biomedicine
(128)
Oncology
(108)
Middle Aged
(97)
Aged
(95)
Adult
(80)
Biological And Medical Sciences
(79)
Medical Sciences
(79)
Breast Neoplasms - Drug Therapy
(69)
Male
(50)
Pharmacology. Drug Treatments
(48)
Antineoplastic Agents
(47)
Tumors
(43)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(41)
Breast Neoplasms - Pathology
(40)
Chemotherapy
(40)
Gynecology. Andrology. Obstetrics
(37)
Mammary Gland Diseases
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

VA.2 Hormone therapy in BC patients with co-morbidities

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA study

Identifying optimal adjuvant treatment for individual patients: young age is still an issue?

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

1084 Neoadjuvant Trastuzumab and Paclitaxel Combination Induces a High Rate of Pathological Complete Responses in Locally Advanced Breast Cancer by Exploiting Host Antitumor Immunity

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring

Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors

Breast carcinoma during pregnancy : International recommendations from an expert meeting

Suchergebnisse filtern